76 related articles for article (PubMed ID: 20528568)
1. Evaluation of UGT1A1 and SULT1A1 polymorphisms with lipid levels in women with different hormonal status.
Smiderle L; Galvão AC; Fontana C; Wender MC; Agnes G; Giovenardi M; Hutz MH; Almeida S
Gynecol Endocrinol; 2011 Jan; 27(1):20-6. PubMed ID: 20528568
[TBL] [Abstract][Full Text] [Related]
2. ESR1 and APOE gene polymorphisms, serum lipids, and hormonal replacement therapy.
Almeida S; Fiegenbaum M; de Andrade FM; Osório-Wender MC; Hutz MH
Maturitas; 2006 May; 54(2):119-26. PubMed ID: 16242874
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor 2 and progesterone receptor gene polymorphisms and lipid levels in women with different hormonal status.
Almeida S; Franken N; Zandoná MR; Osório-Wender MC; Hutz MH
Pharmacogenomics J; 2005; 5(1):30-4. PubMed ID: 15381922
[TBL] [Abstract][Full Text] [Related]
4. [Association of polymorphisms in SULT1A1 and UGT1A1 Genes with breast cancer risk and phenotypes in Russian women].
Shatalova EG; Loginov VI; Braga EA; Kazubskaia TP; Sudomoina MA; Blanchard RL; Favorova OO
Mol Biol (Mosk); 2006; 40(2):263-70. PubMed ID: 16637266
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms in human SULT1A1 and UGT1A1 genes associate with breast tumor characteristics: a case-series study.
Shatalova EG; Walther SE; Favorova OO; Rebbeck TR; Blanchard RL
Breast Cancer Res; 2005; 7(6):R909-21. PubMed ID: 16280036
[TBL] [Abstract][Full Text] [Related]
6. The impact of female hormone usage on the lipid profile. The Framingham Offspring Study.
Vaziri SM; Evans JC; Larson MG; Wilson PW
Arch Intern Med; 1993 Oct; 153(19):2200-6. PubMed ID: 8215723
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein metabolism in postmenopausal and oophorectomized women.
Wakatsuki A; Sagara Y
Obstet Gynecol; 1995 Apr; 85(4):523-8. PubMed ID: 7898827
[TBL] [Abstract][Full Text] [Related]
8. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH
Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor alpha and beta polymorphisms: is there an association with bone mineral density, plasma lipids, and response to postmenopausal hormone therapy?
Silvestri S; Thomsen AB; Gozzini A; Bagger Y; Christiansen C; Brandi ML
Menopause; 2006; 13(3):451-61. PubMed ID: 16735942
[TBL] [Abstract][Full Text] [Related]
10. A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.
Davidson MH; Testolin LM; Maki KC; von Duvillard S; Drennan KB
Arch Intern Med; 1997 Jun; 157(11):1186-92. PubMed ID: 9183229
[TBL] [Abstract][Full Text] [Related]
11. Endogenous estrogen and androgen levels are not independent predictors of lipid levels in postmenopausal women.
Worsley R; Robinson PJ; Bell RJ; Moufarege A; Davis SR
Menopause; 2013 Jun; 20(6):640-5. PubMed ID: 23531683
[TBL] [Abstract][Full Text] [Related]
12. [Effects of tamoxifen and estrogen replacement therapy on lipid metabolism and some other cardiovascular risk factors. A prospective study in hysterectomised women].
Imperato F; Marziani R; Perniola G; Ebano V; Fruscella M; Mossa B
Minerva Ginecol; 2003 Feb; 55(1):87-93. PubMed ID: 12598849
[TBL] [Abstract][Full Text] [Related]
13. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
Araújo DA; Farias ML; Andrade AT
Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
[TBL] [Abstract][Full Text] [Related]
14. Impact of genetic factors on dyslipidemia in HIV-infected patients starting antiretroviral therapy.
Egaña-Gorroño L; Martínez E; Cormand B; Escribà T; Gatell J; Arnedo M
AIDS; 2013 Feb; 27(4):529-38. PubMed ID: 23262498
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
Breast Cancer Res Treat; 2010 Jan; 119(2):463-74. PubMed ID: 19424794
[TBL] [Abstract][Full Text] [Related]
16. Three-year study of estrogen alone versus combined with progestin in postmenopausal women with or without hypercholesterolemia.
Sanada M; Nakagawa H; Kodama I; Sakasita T; Ohama K
Metabolism; 2000 Jun; 49(6):784-9. PubMed ID: 10877207
[TBL] [Abstract][Full Text] [Related]
17. Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease.
Herrington DM; Howard TD; Hawkins GA; Reboussin DM; Xu J; Zheng SL; Brosnihan KB; Meyers DA; Bleecker ER
N Engl J Med; 2002 Mar; 346(13):967-74. PubMed ID: 11919305
[TBL] [Abstract][Full Text] [Related]
18. Lipid profiles and bone mineral density in pre- and postmenopausal women in Korea.
Jeong IK; Cho SW; Kim SW; Choi HJ; Park KS; Kim SY; Lee HK; Cho SH; Oh BH; Shin CS
Calcif Tissue Int; 2010 Dec; 87(6):507-12. PubMed ID: 20976443
[TBL] [Abstract][Full Text] [Related]
19. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
[TBL] [Abstract][Full Text] [Related]
20. Are polymorphisms in oestrogen receptors genes associated with lipid levels in response to hormone therapy?
Smiderle L; Mattevi VS; Giovenardi M; Wender MC; Hutz MH; Almeida S
Gynecol Endocrinol; 2012 Aug; 28(8):644-8. PubMed ID: 22324545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
